This cross-sectional study investigates healthcare utilization, and determines which predisposing, enabling, and health factors are associated with healthcare utilization among 121 patients with multiple sclerosis (MS).
Methods
Data on patient-related predisposing, enabling, and health factors were collected by means of written questionnaires and a home visit from a well-trained physiotherapist.
Results
Of the 121 patients with MS (mean age 43 years, mean score on the Expanded Disability Status Scale 3.5, disease duration 6 years), 16% were hospitalized in the previous year; 62% consulted their general practitioner, and 69% consulted their neurologist in the previous 6 months. Other medical specialists were consulted in the 6-month period by 50% of the study population. In a 4-week period preceding the home visit, 41% of the patients were treated by an allied healthcare professional. Multivariate logistic regression analyses showed that consulting the general practitioner, the neurologist, other medical specialists, and allied healthcare professionals, and the use of equipment/aids by MS patients is primarily related to their health, either as perceived by the patients themselves or defined by the professional.
Conclusions
MS patients in the Netherlands make appropriate use of healthcare facilities, because their utilization can predominantly be explained by health-related factors, and not by predisposing or enabling factors.
1 Wolfson AM Doctor JN Burns SP . Clinician judgments of functional outcomes: how bias and perceived accuracy affect rating. Arch Phys Med Rehabil2000; 81: 1567–1574.
2.
2 Rothwell PM McDowell Z Wong CK Dorman PJ . Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ1997; 314: 1580–1583.
3.
3 Cardol M de Jong BA van den Bos GA Beelen A de Groot IJ de Haan RJ . Beyond disability: perceived participation in people with a chronic disabling condition. Clin Rehabil2002; 16: 27–35.
4.
4 Mars GM Proot IM Janssen PP van Eijk JT Kempen GI . How do people with COPD or diabetes type 2 experience autonomy? An exploratory study. Disabil Rehabil2007; 29: 485–493.
5.
5 Berkanovic E Hurwicz ML Lachenbruch PA . Concordant and discrepant views of patients’ physical functioning. Arthritis Care Res1995; 8: 94–101.
6.
6 Isaksson A-K Ahlström G Gunnarsson L-G . Quality of Life and impairment in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry2005; 76: 64–69.
7.
7 Andersen RM . Revisiting the behavioral model and access to medical care: does it matter. J Health Soc Behav1995; 36: 1–10.
8.
8 Gelberg L Andersen RM Leake BD . The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res2000; 34: 1273–1302.
9.
9 Goodwin R Andersen RM . Use of the Behavioral Model of Health Care Use to identify correlates of use of treatment for panic attacks in the community. Soc Psychiatry Psychiatr Epidemiol2002; 37: 212–219.
10.
10 Poser CM Paty DW Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
11.
11 de Groot V Beckerman H Lankhorst GJ Polman CH Bouter LM . The initial clinical course of patients with multiple sclerosis: three-year follow-up study. Mult Scler2005; 11: 713–718.
12.
12 Wallston KA Wallston BS DeVellis R . Development of the multidimensional health locus of control scales. Health Educ Monogr1978; 6: 160–170.
13.
13 Halfens RJ Philipsen H . Een gezondheidsspecifieke beheersingsoriëntatieschaal: validiteit en betrouwbaarheid van de MHLC. T Soc Gezond1988; 66: 399–403.
15 Plochg T Delnoij DM van der Kruk TF Janmaat TA Klazinga NS . Intermediate care: for better or worse? Process evaluation of an intermediate care model between a university hospital and a residential home. BMC Health Serv Res2005; 5: 38.
16.
16 Oeseburg B Jansen D De Keyser J . Reducing discrepancies between MS patients’ needs and use of healthcare services by applying a transmural care model. J Neurosci Nurs2004; 36: 214–219, 230.
17.
17 Jörg F Borgers N Schrijvers AJP Hox JJ . Variation in long-term care needs assessors’ willingness to support clients’ requests for admission to a residential home: a vignette study. J Aging Health2006; 18: 767–790.
18.
18 Ricketts TC Goldsmith LJ . Access in health services research: the battle of the frameworks. Nurs Outlook2005; 53: 274–280.
19.
19 Cardol M de Haan RJ van den Bos GA de Jong BA de Groot IJ . The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil1999; 13: 411–419.
20.
20 Vazirinejad R Lilley JM Ward CD . The 'Impact on Participation and Autonomy': acceptability of the English version in a multiple sclerosis outpatient setting. Mult Scler2003; 9: 612–615.
21.
21 Ware JE Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care1992; 30: 473–483.
22.
22 Ware JE Snow KK Kosinski M Gandek B . SF-36 Health survey manual and interpretation guide.Boston, MA: New England Medical Center, The Health Institute; 1993.
23.
23 Dallmeijer AJ Dekker J Knol DL . on behalf of the FuPro study group. Dimensional structure of the SF-36 in neurological patients. J Clin Epidemiol2006; 59: 541–543.
24.
24 Hobart J Freeman J Lamping D Fitzpatrick R Thompson A . The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry2001; 71: 363–370.
25.
25 The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy1990; 16: 199–208.
26.
26 Lamers LM Stalmeier PFM McDoneel J Krabbe PFM van Busschbach JJ . Kwaliteit van leven meten in economische evaluaties: het Nederlands EQ-5D-tarief. Ned Tijdschr Geneeskd2005; 149: 1574–1578.
27.
27 Krupp LB LaRocca NG Muir-Nash J Steinberg AD . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
28.
28 Radloff LS . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas1977; 1: 385–401.
29.
29 Beekman ATF Deeg DJH van Limbeek J Braam AW de Vries MZ van Tilburg W . Criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol Med1997; 27: 231–235.
30.
30 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology1983; 33: 1444–1452.
31.
31 Linn BS Linn MW Gurel L . Cumulative illness rating scale. J Am Geriatr Soc1968; 16: 622–626.
32.
32 de Groot V Beckerman H Lankhorst GJ Bouter LM . How to measure comorbidity: a critical review of available methods. J Clin Epidemiol2003; 56: 221–229.
33.
33 Kobelt G Berg J Lindgren P Fredrikson S Jönsson B . Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry2006; 77: 918–926.
34.
34 Kobelt G Berg J Lindgren P . Costs and quality of life in multiple sclerosis in the Netherlands. Eur J Health Econ2006; 7: S55–S64.
35.
35 Moorer P Suurmeijer TH Zwanikken CP . Health care utilization by people with multiple sclerosis in the Netherlands: results of two separate studies. Disabil Rehabil2000; 22: 695–701.
36.
36 Patwardhan MB Matchar DB Samsa GP McCrory DC Williams RG Li TT . Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler2005; 11: 232–239.
37.
37 MacLurg K Reilly P Hawkins S Gray O Evason E Whittington D . A primary care-based needs assessment of people with multiple sclerosis. Br J Gen Pract2005; 55: 378–383.
38.
38 Kobelt G Berg J Atherly D Hadjimichael O . Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology2006; 66: 1696–1702.
39.
39 Taylor B McDonald E Fantino B . The cost of multiple sclerosis in Australia. J Clin Neurosci2007; 14: 532–539.
40.
40 Mackenbach JP Borsboom GJ Nusselder WJ Looman CW Schrijvers CT . Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study. J Epidemiol Community Health2001; 55: 631–638.
41.
41 Nusselder WJ Looman CW Mackenbach JP . Non-disease factors affected trajectories of disability in a prospective study. J Clin Epidemiol2005; 58: 484–494.
42.
42 Nusselder WJ Looman CW Mackenbach JP . The level and time course of disability: trajectories of disability in adults and young elderly. Disabil Rehabil2006; 28: 1015–1026.
